{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T19:17:46Z","timestamp":1783711066564,"version":"3.55.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-026-10646-y","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T06:36:33Z","timestamp":1783665393000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Heart failure with mildly reduced ejection fraction (HFmrEF): where are we now?"],"prefix":"10.1007","volume":"31","author":[{"given":"Muhammad","family":"Memon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Qadeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafeez Ul Hassan","family":"Virk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Affan","family":"Rizwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paritosh Perry","family":"Coomar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboob","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzamil","family":"Khawaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Rodriguez","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. H. Wilson","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chayakrit","family":"Krittanawong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"10646_CR1","doi-asserted-by":"publisher","unstructured":"Savarese G, Stolfo D et al Heart failure with mid-range or mildly reduced ejection fraction. Nature Reviews Cardiology Published online September 6, 2021:1\u201317. https:\/\/doi.org\/10.1038\/S41569-021-00605-5","DOI":"10.1038\/S41569-021-00605-5"},{"issue":"1","key":"10646_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S11897-019-00451-0","volume":"17","author":"PK Srivastava","year":"2020","unstructured":"Srivastava PK, Hsu JJ, Ziaeian B, Ziaeian B, Fonarow GC (2020) Heart Failure With Mid-range Ejection Fraction. Curr Heart Fail Rep 17(1):1\u20138. https:\/\/doi.org\/10.1007\/S11897-019-00451-0","journal-title":"Curr Heart Fail Rep"},{"issue":"8","key":"10646_CR3","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.034642","volume":"13","author":"M Packer","year":"2024","unstructured":"Packer M (2024) Left Ventricular Ejection Fraction in Heart Failure: Crazy, Stupid Love-and Maybe, Redemption. J Am Heart Assoc 13(8):e034642. https:\/\/doi.org\/10.1161\/JAHA.124.034642","journal-title":"J Am Heart Assoc"},{"key":"10646_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ijcard.2023.01.072","volume":"376","author":"S Wernhart","year":"2023","unstructured":"Wernhart S, Papathanasiou M, Rassaf T, Luedike P (2023) Heart failure classification based on resting ejection fraction does not display a unique exercise response pattern. Int J Cardiol 376:157\u2013164. https:\/\/doi.org\/10.1016\/j.ijcard.2023.01.072","journal-title":"Int J Cardiol"},{"issue":"11","key":"10646_CR5","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.jchf.2017.08.011","volume":"5","author":"GC Fonarow","year":"2017","unstructured":"Fonarow GC (2017) Refining Classification of Heart Failure Based on Ejection Fraction. JACC Heart Fail 5(11):808\u2013809. https:\/\/doi.org\/10.1016\/j.jchf.2017.08.011","journal-title":"JACC Heart Fail"},{"issue":"3","key":"10646_CR6","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/ehf2.1220","volume":"5","author":"Y Shiraishi","year":"2018","unstructured":"Shiraishi Y, Yamaguchi J, Haruta S et al (2018) Prognostic impact of the use of mineralocorticoid receptor antagonists in patients with heart failure with mid-range ejection fraction: a report from the CHART-2 Study and the JCARE-CARD Registry. ESC Heart Fail 5(3):342\u2013352. https:\/\/doi.org\/10.1002\/ehf2.1220","journal-title":"ESC Heart Fail"},{"key":"10646_CR7","doi-asserted-by":"publisher","unstructured":"(2015) Exercise Training in Patients With Heart Failure and Preserved Ejection Fraction. Circ Heart Fail 8(1):33\u201340. https:\/\/doi.org\/10.1161\/circheartfailure.114.001615","DOI":"10.1161\/circheartfailure.114.001615"},{"key":"10646_CR8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/00015385.2022.2059135","volume":"78","author":"A Guti\u00e9rrez","year":"2022","unstructured":"Guti\u00e9rrez A, Grados Saso D, Esteban Cabello EI et al (2022) Clinical characteristics of heart failure patients with mid-range ejection fraction. Acta Cardiol 78:233\u2013240. https:\/\/doi.org\/10.1080\/00015385.2022.2059135","journal-title":"Acta Cardiol"},{"issue":"1","key":"10646_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/j.2040-4603.2016.tb00669.x","volume":"6","author":"E Tanai","year":"2016","unstructured":"Tanai E, Frantz S (2016) Pathophysiology of Heart Failure. Compr Physiol 6(1):187\u2013214. https:\/\/doi.org\/10.1002\/j.2040-4603.2016.tb00669.x","journal-title":"Compr Physiol"},{"key":"10646_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.678614","volume":"8","author":"P Li","year":"2021","unstructured":"Li P, Zhao H, Zhang J, Ning Y, Tu Y, Xu D, Zeng Q (2021) Similarities and Differences Between HFmrEF and HFpEF. Front Cardiovasc Med 8:678614. https:\/\/doi.org\/10.3389\/fcvm.2021.678614","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"10646_CR11","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/J.JCHF.2017.06.013","volume":"5","author":"JJ Hsu","year":"2017","unstructured":"Hsu JJ, Ziaeian B, Fonarow GC (2017) Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions. Jacc-Heart Fail 5(11):763\u2013771. https:\/\/doi.org\/10.1016\/J.JCHF.2017.06.013","journal-title":"Jacc-Heart Fail"},{"issue":"1","key":"10646_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1161\/CIRCHEARTFAILURE.109.931451","volume":"4","author":"D Westermann","year":"2011","unstructured":"Westermann D, Lindner D, Kasner M, Zietsch C, Savvatis K, Escher F, von Schlippenbach J, Skurk C, Steendijk P, Riad A, Poller W, Schultheiss HP, Tsch\u00f6pe C (2011) Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ Heart Fail 4(1):44\u201352. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.109.931451","journal-title":"Circ Heart Fail"},{"issue":"10","key":"10646_CR13","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1097\/HJH.0000000000002504","volume":"38","author":"G Pichler","year":"2020","unstructured":"Pichler G, Redon J, Mart\u00ednez F, Solaz E, Calaforra O, Andr\u00e9s MS, Lopez B, D\u00edez J, Oberbauer R, Adlbrecht C, Karth GD, Maceira A (2020) Cardiac magnetic resonance-derived fibrosis, strain and molecular biomarkers of fibrosis in hypertensive heart disease. J Hypertens 38(10):2036\u20132042. https:\/\/doi.org\/10.1097\/HJH.0000000000002504","journal-title":"J Hypertens"},{"issue":"20","key":"10646_CR14","doi-asserted-by":"publisher","first-page":"15472","DOI":"10.3390\/ijms242015472","volume":"24","author":"AA Manolis","year":"2023","unstructured":"Manolis AA, Manolis TA, Manolis AS (2023) Neurohumoral Activation in Heart Failure. Int J Mol Sci 24(20):15472. https:\/\/doi.org\/10.3390\/ijms242015472","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10646_CR15","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.cardfail.2008.10.031","volume":"15","author":"O Morel","year":"2009","unstructured":"Morel O, Sauer FC, Imp\u00e9riale A, Sauer F et al (2009) Importance of inflammation and neurohumoral activation in Takotsubo cardiomyopathy. J Card Fail 15(3):206\u2013213. https:\/\/doi.org\/10.1016\/j.cardfail.2008.10.031","journal-title":"J Card Fail"},{"key":"10646_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ijcard.2019.08.040","volume":"296","author":"L Zyw","year":"2019","unstructured":"Zyw L (2019) Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction. Int J Cardiol 296:91\u201397. https:\/\/doi.org\/10.1016\/j.ijcard.2019.08.040","journal-title":"Int J Cardiol"},{"key":"10646_CR17","doi-asserted-by":"publisher","unstructured":"D\u2019Amario D, Migliaro S, Borovac JA, Restivo A, Vergallo R, Galli M, Leone AM, Montone RA, Niccoli G, Aspromonte N, Crea F (2019) Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction. Front Physiol 10:1347. https:\/\/doi.org\/10.3389\/fphys.2019.01347 PMID: 31749710; PMCID: PMC6848263","DOI":"10.3389\/fphys.2019.01347"},{"issue":"18","key":"10646_CR18","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1093\/cvr\/cvac166","volume":"118","author":"F Capone","year":"2023","unstructured":"Capone F, Sotomayor-Flores C, Bode D, Wang R, Rodolico D, Strocchi S, Schiattarella GG (2023) Cardiac metabolism in HFpEF: from fuel to signalling. Cardiovasc Res 118(18):3556\u20133575. https:\/\/doi.org\/10.1093\/cvr\/cvac166","journal-title":"Cardiovasc Res"},{"issue":"18","key":"10646_CR19","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.jacc.2009.07.024","volume":"54","author":"LH Opie","year":"2009","unstructured":"Opie LH, Knuuti J (2009) The adrenergic-fatty acid load in heart failure. J Am Coll Cardiol 54(18):1637\u201346. https:\/\/doi.org\/10.1016\/j.jacc.2009.07.024","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10646_CR20","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s10741-020-09913-3","volume":"26","author":"SW Rabkin","year":"2021","unstructured":"Rabkin SW, Tang JKK (2021) The utility of growth differentiation factor-15, galectin-3, and sST2 as biomarkers for the diagnosis of heart failure with preserved ejection fraction and compared to heart failure with reduced ejection fraction: a systematic review. Heart Fail Rev 26(4):799\u2013812. https:\/\/doi.org\/10.1007\/s10741-020-09913-3","journal-title":"Heart Fail Rev"},{"key":"10646_CR21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijcard.2020.01.039","volume":"304","author":"Y Song","year":"2020","unstructured":"Song Y, Li F, Xu Y et al (2020) Prognostic value of sST2 in patients with heart failure with reduced, mid-range and preserved ejection fraction. Int J Cardiol 304:95\u2013100. https:\/\/doi.org\/10.1016\/j.ijcard.2020.01.039","journal-title":"Int J Cardiol"},{"issue":"4","key":"10646_CR22","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41588-025-02140-2","volume":"57","author":"DSM Lee","year":"2025","unstructured":"Lee DSM, Cardone KM, Zhang DY et al (2025) Common-variant and rare-variant genetic architecture of heart failure across the allele-frequency spectrum. Nat Genet 57(4):829\u2013838. https:\/\/doi.org\/10.1038\/s41588-025-02140-2","journal-title":"Nat Genet"},{"issue":"4","key":"10646_CR23","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/jamacardio.2020.6500","volume":"6","author":"G Povysil","year":"2021","unstructured":"Povysil G, Chazara O, Carss KJ et al (2021) Assessing the role of rare genetic variation in patients with heart failure. JAMA Cardiol 6(4):379\u2013386. https:\/\/doi.org\/10.1001\/jamacardio.2020.6500","journal-title":"JAMA Cardiol"},{"key":"10646_CR24","doi-asserted-by":"publisher","unstructured":"Bielecka-Dabrowa A, Sakowicz A, Pietrucha T et al (2017) The profile of selected single nucleotide polymorphisms in patients with hypertension and heart failure with preserved and mid-range ejection fraction. Sci Rep 7(1):8974, 8974. https:\/\/doi.org\/10.1038\/s41598-017-09564-9","DOI":"10.1038\/s41598-017-09564-9"},{"issue":"4","key":"10646_CR25","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/s41588-024-02064-3","volume":"57","author":"A Henry","year":"2025","unstructured":"Henry A, Mo X, Finan C et al (2025) Genome-wide association study meta-analysis provides insights into the etiology of heart failure and its subtypes. Nat Genet 57(4):815\u2013828. https:\/\/doi.org\/10.1038\/s41588-024-02064-3","journal-title":"Nat Genet"},{"issue":"6","key":"10646_CR26","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004646","volume":"11","author":"A Sharma","year":"2018","unstructured":"Sharma A, Zhao X, Hammill BG et al (2018) Trends in noncardiovascular comorbidities among patients hospitalized for heart failure: insights from the Get With The Guidelines-Heart Failure Registry. Circ Heart Fail 11(6):e004646. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.117.004646","journal-title":"Circ Heart Fail"},{"issue":"4","key":"10646_CR27","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jchf.2018.11.019","volume":"7","author":"G Savarese","year":"2019","unstructured":"Savarese G, Vedin O, D\u2019Amario D et al (2019) Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure. JACC: Heart Fail 7(4):306\u2013317. https:\/\/doi.org\/10.1016\/j.jchf.2018.11.019","journal-title":"JACC: Heart Fail"},{"issue":"10","key":"10646_CR28","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/ejhf.807","volume":"19","author":"K Tsuji","year":"2017","unstructured":"Tsuji K, Sakata Y, Nochioka K et al (2017) Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 Study. Eur J Heart Fail 19(10):1258\u20131269. https:\/\/doi.org\/10.1002\/ejhf.807","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10646_CR29","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.122.010252","volume":"16","author":"AE Peters","year":"2023","unstructured":"Peters AE, Clare RM, Chiswell K et al (2023) Echocardiographic features beyond ejection fraction and associated outcomes in patients with heart failure with mildly reduced or preserved ejection fraction. Circ Heart Fail 16(5):e010252. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.122.010252","journal-title":"Circ Heart Fail"},{"issue":"2","key":"10646_CR30","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1161\/CIRCRESAHA.116.309128","volume":"119","author":"AM Omar","year":"2016","unstructured":"Omar AM, Bansal M, Sengupta PP (2016) Advances in Echocardiographic Imaging in Heart Failure With Reduced and Preserved Ejection Fraction. Circ Res 119(2):357\u2013374. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.309128","journal-title":"Circ Res"},{"key":"10646_CR31","doi-asserted-by":"publisher","unstructured":"Stacey RB, Hundley WG (2013) The Role of Cardiovascular Magnetic Resonance (CMR) and Computed Tomography (CCT) in Facilitating Heart Failure Management. Curr Treat Options Cardiovasc Med 15(4):373\u2013386. https:\/\/doi.org\/10.1007\/s11936-013-0253-6 PMID: 23817725; PMCID: PMC3767383","DOI":"10.1007\/s11936-013-0253-6"},{"issue":"7","key":"10646_CR32","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1093\/ehjci\/jez014","volume":"20","author":"NR Pugliese","year":"2019","unstructured":"Pugliese NR, Fabiani I, Santini C et al (2019) Value of combined cardiopulmonary and echocardiography stress test to characterize the haemodynamic and metabolic responses of patients with heart failure and mid-range ejection fraction. Eur Heart J Cardiovasc Imaging 20(7):828\u2013836. https:\/\/doi.org\/10.1093\/ehjci\/jez014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"17","key":"10646_CR33","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D et al (2022) 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 79(17):e263\u2013e421. https:\/\/doi.org\/10.1016\/j.jacc.2021.12.012","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10646_CR34","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1002\/ejhf.1149","volume":"20","author":"LH Lund","year":"2018","unstructured":"Lund LH, Claggett B, Liu J et al (2018) Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum. Eur J Heart Fail 20(8):1230\u20131239. https:\/\/doi.org\/10.1002\/ejhf.1149","journal-title":"Eur J Heart Fail"},{"issue":"20","key":"10646_CR35","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1001\/jama.2012.14785","volume":"308","author":"LH Lund","year":"2012","unstructured":"Lund LH, Benson L, Dahlstr\u00f6m U, Edner M (2012) Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction. JAMA 308(20):2108\u201317. https:\/\/doi.org\/10.1001\/jama.2012.14785","journal-title":"JAMA"},{"issue":"15","key":"10646_CR36","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1001\/jama.2023.20452","volume":"330","author":"SD Solomon","year":"2023","unstructured":"Solomon SD, Vaduganathan M, Claggett BL et al (2023) Angiotensin\u2013neprilysin inhibition in heart failure with preserved ejection fraction: primary results of the PARAGLIDE-HF trial. JAMA 330(15):1439\u20131449. https:\/\/doi.org\/10.1001\/jama.2023.20452","journal-title":"JAMA"},{"issue":"3","key":"10646_CR37","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1161\/CIRCHEARTFAILURE.107.740597","volume":"1","author":"A Ahmed","year":"2006","unstructured":"Ahmed A, Rich MW, Fleg JL et al (2006) Effects of digoxin on morbidity and mortality in diastolic heart failure: a post hoc analysis of the DIG trial. Circ Heart Fail 1(3):144\u2013152. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.107.740597","journal-title":"Circ Heart Fail"},{"issue":"1","key":"10646_CR38","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/eurheartj\/ehx564","volume":"39","author":"JGF Cleland","year":"2018","unstructured":"Cleland JGF, Bunting KV, Flather MD et al (2018) Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials. Eur Heart J 39(1):26\u201335. https:\/\/doi.org\/10.1093\/eurheartj\/ehx564","journal-title":"Eur Heart J"},{"key":"10646_CR39","doi-asserted-by":"publisher","first-page":"1374926","DOI":"10.3389\/fphys.2024.1374926","volume":"15","author":"Y Chen","year":"2024","unstructured":"Chen Y, Zhang J, Liu S et al (2024) Addition of Baduanjin Qigong to cardiac rehabilitation in patients with heart failure with preserved or mildly reduced ejection fraction: a randomized controlled trial. Front Physiol 15:1374926. https:\/\/doi.org\/10.3389\/fphys.2024.1374926","journal-title":"Front Physiol"},{"issue":"1","key":"10646_CR40","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1001\/jama.2015.17346","volume":"315","author":"DW Kitzman","year":"2016","unstructured":"Kitzman DW, Brubaker PH, Morgan TM et al (2016) Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: a randomized clinical trial. JAMA 315(1):36\u201346. https:\/\/doi.org\/10.1001\/jama.2015.17346","journal-title":"JAMA"},{"key":"10646_CR41","doi-asserted-by":"publisher","unstructured":"Simultaneous or Rapid Initiation of Combination Therapy for Heart Failure With Preserved Ejection Fraction, Greene SJ, Butler J, Fonarow GCJAMA, Cardiol (2025) Mar 5. https:\/\/doi.org\/10.1001\/jamacardio.2025.0038. Online ahead of print.PMID: 40042835)","DOI":"10.1001\/jamacardio.2025.0038"},{"issue":"12","key":"10646_CR42","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1038\/s41591-022-02041-5","volume":"28","author":"SD Anker","year":"2022","unstructured":"Anker SD, Butler J, Usman MS et al (2022) Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved. Nat Med 28(12):2512\u20132520. https:\/\/doi.org\/10.1038\/s41591-022-02041-5","journal-title":"Nat Med"},{"issue":"12","key":"10646_CR43","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","volume":"387","author":"SD Solomon","year":"2022","unstructured":"Solomon SD, McMurray JJV, Claggett B et al (2022) Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med 387(12):1089\u20131098. https:\/\/doi.org\/10.1056\/NEJMoa2206286","journal-title":"N Engl J Med"},{"issue":"2","key":"10646_CR44","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/eurheartj\/ehi687","volume":"27","author":"A Ahmed","year":"2006","unstructured":"Ahmed A, Rich MW, Love TE, Lloyd-Jones DM, Aban IB, Colucci WS, Adams KF, Gheorghiade M (2006) Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur Heart J 27(2):178\u2013186. https:\/\/doi.org\/10.1093\/eurheartj\/ehi687","journal-title":"Eur Heart J"},{"issue":"1","key":"10646_CR45","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1161\/CIRCHEARTFAILURE.114.001615","volume":"8","author":"A Pandey","year":"2015","unstructured":"Pandey A, Parashar A, Kumbhani D, Agarwal S, Garg J, Kitzman D, Levine B, Drazner M, Berry J (2015) Exercise training in patients with heart failure and preserved ejection fraction: meta-analysis of randomized control trials. Circ Heart Fail 8(1):33\u201340. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.114.001615","journal-title":"Circ Heart Fail"},{"key":"10646_CR46","unstructured":"Chen JZ (2024) Effects of standing baduanjin exercise on quality of life and exercise tolerance in elderly patients with heart failure and frailty. China J Integr Med Cardio Cerebrovasc Dis 12(6):71\u20133."},{"key":"10646_CR47","doi-asserted-by":"publisher","unstructured":"Menasch\u00e9 P, Renault NK, Hag\u00e8ge A, Puscas T, Bellamy V, Humbert C, Le L, Blons H, Granier C, Benhamouda N, Bacher A, Churlaud G, Sabatier B, Larghero J (2024) First-in-man use of a cardiovascular cell-derived secretome in heart failure. Case report. EBioMedicine. 103:105145. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105145","DOI":"10.1016\/j.ebiom.2024.105145"},{"key":"10646_CR48","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1056\/NEJMoa042739","volume":"351","author":"E Braunwald","year":"2004","unstructured":"Braunwald E, Domanski MJ, Fowler SE et al (2004) Angiotensin-converting\u2013enzyme inhibition in stable coronary artery disease. N Engl J Med 351:2058\u20132068","journal-title":"N Engl J Med"},{"issue":"17","key":"10646_CR49","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV, Jackson AM, Lam CSP et al (2019) PARAGON-HF Investigators and Committees. Angiotensin\u2013neprilysin inhibition in heart failure with preserved ejection fraction. N Engl J Med 381(17):1609\u20131620. https:\/\/doi.org\/10.1056\/NEJMoa1908655","journal-title":"N Engl J Med"},{"issue":"5","key":"10646_CR50","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1161\/CIRCULATIONAHA.119.044586","volume":"141","author":"SD Solomon","year":"2020","unstructured":"Solomon SD, Vaduganathan M, Claggett L (2020) Sacubitril\/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure. Circulation 141(5):352\u2013361. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.044586","journal-title":"Circulation"},{"issue":"31","key":"10646_CR51","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1093\/eurheartj\/ehad344","volume":"44","author":"M Vaduganathan","year":"2023","unstructured":"Vaduganathan M, Mentz RJ, Claggett BL et al (2023) Sacubitril\/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF. Eur Heart J 44(31):2982\u20132993. https:\/\/doi.org\/10.1093\/eurheartj\/ehad344","journal-title":"Eur Heart J"},{"key":"10646_CR52","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.jchf.2023.03.017","volume":"11","author":"SV Arnold","year":"2023","unstructured":"Arnold SV, Silverman DN, Gosch K et al (2023) Beta-blocker use and heart failure outcomes in mildly reduced and preserved ejection fraction. JACC Heart Fail 11:893\u2013900. https:\/\/doi.org\/10.1016\/j.jchf.2023.03.017","journal-title":"JACC Heart Fail"},{"issue":"10458","key":"10646_CR53","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S0140-6736(24)01733-1","volume":"404","author":"PS Jhund","year":"2024","unstructured":"Jhund PS, Talebi A, Henderson AD et al (2024) Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis. Lancet 404(10458):1119\u20131131. https:\/\/doi.org\/10.1016\/S0140-6736(24)01733-1","journal-title":"Lancet"},{"key":"10646_CR54","doi-asserted-by":"publisher","unstructured":"(2014) Spironolactone for Heart Failure with Preserved Ejection Fraction. N Engl J Med 370(15):1383\u20131392. https:\/\/doi.org\/10.1056\/nejmoa1313731","DOI":"10.1056\/nejmoa1313731"},{"key":"10646_CR55","unstructured":"Lam CSP, Filippatos G, Butler J et al FINEARTS-HF Investigators. Finerenone in heart failure with preserved or mildly reduced ejection fraction.\u00a0N Engl J Med. 2024;390(15):1393\u20131404. doi:10.1056\/NEJMoa2402045"},{"issue":"21","key":"10646_CR56","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1056\/NEJMra2115011","volume":"386","author":"E Braunwald","year":"2022","unstructured":"Braunwald E (2022) Gliflozins in the management of cardiovascular disease. N Engl J Med 386(21):2024\u20132034. https:\/\/doi.org\/10.1056\/NEJMra2115011","journal-title":"N Engl J Med"},{"key":"10646_CR57","doi-asserted-by":"publisher","unstructured":"Rashed A, Wasef M, Kalra PR (2023) The 2023 European Society of Cardiology (ESC) heart failure guideline update and its implications for clinical practice. Br J Cardiol 31(2):023, 023. https:\/\/doi.org\/10.5837\/bjc.2024.023","DOI":"10.5837\/bjc.2024.023"},{"issue":"10437","key":"10646_CR58","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/S0140-6736(24)00469-0","volume":"403","author":"J Butler","year":"2024","unstructured":"Butler J, Shah SJ, Petrie MC et al (2024) Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials. Lancet 403(10437):1635\u20131648. https:\/\/doi.org\/10.1016\/S0140-6736(24)00469-0","journal-title":"Lancet"},{"issue":"3","key":"10646_CR59","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1161\/CIRCULATIONAHA.123.067505","volume":"149","author":"MN Kosiborod","year":"2024","unstructured":"Kosiborod MN, Verma S, Borlaug BA et al (2024) Effects of semaglutide on symptoms, function, and quality of life in patients with heart failure with preserved ejection fraction and obesity: a prespecified analysis of the STEP-HFpEF trial. Circulation 149(3):204\u2013216. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.067505","journal-title":"Circulation"},{"issue":"1","key":"10646_CR60","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1210\/clinem\/dgad398","volume":"109","author":"JP Ferreira","year":"2023","unstructured":"Ferreira JP, Sharma A, Butler J et al (2023) Glucagon-like peptide-1 receptor agonists across the spectrum of heart failure. J Clin Endocrinol Metab 109(1):4\u20139. https:\/\/doi.org\/10.1210\/clinem\/dgad398","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10646_CR61","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/ejhf.1160","volume":"20","author":"AH Abdul-Rahim","year":"2018","unstructured":"Abdul-Rahim AH, Shen L, Rush CJ et al (2018) Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction. Eur J Heart Fail 20(7):1139\u20131145. https:\/\/doi.org\/10.1002\/ejhf.1160","journal-title":"Eur J Heart Fail"},{"issue":"15","key":"10646_CR62","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.jacc.2023.12.024","volume":"83","author":"TM Maddox","year":"2024","unstructured":"Maddox TM, Januzzi JL Jr, Allen LA et al (2024) 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 83(15):1444\u20131488. https:\/\/doi.org\/10.1016\/j.jacc.2023.12.024","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"10646_CR63","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/j.jacc.2017.08.038","volume":"70","author":"JS Koruth","year":"2017","unstructured":"Koruth JS, Lala A, Pinney S, Reddy VY, Dukkipati SR (2017) The Clinical Use of Ivabradine. J Am Coll Cardiol 70(14):1777\u20131784. https:\/\/doi.org\/10.1016\/j.jacc.2017.08.038","journal-title":"J Am Coll Cardiol"},{"key":"10646_CR64","doi-asserted-by":"publisher","unstructured":"Taylor AL, Ziesche S, Yancy CW, Taylor M et al (2007) Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate\/hydralazine: consistency across subgroups in the African-American Heart Failure Trial. Circulation 115(13):1747\u201353. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.644013","DOI":"10.1161\/CIRCULATIONAHA.106.644013"},{"issue":"20","key":"10646_CR65","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1056\/NEJMra1703100","volume":"377","author":"DH Ellison","year":"2017","unstructured":"Ellison DH, Felker GM (2017) Diuretic treatment in heart failure. N Engl J Med 377(20):1964\u20131975. https:\/\/doi.org\/10.1056\/NEJMra1703100","journal-title":"N Engl J Med"},{"issue":"4","key":"10646_CR66","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.jchf.2023.07.014","volume":"12","author":"S Zafeiropoulos","year":"2024","unstructured":"Zafeiropoulos S, Farmakis IT, Milioglou I et al (2024) Pharmacological Treatments in Heart Failure With Mildly Reduced and Preserved Ejection Fraction: Systematic Review and Network Meta-Analysis. JACC Heart Fail 12(4):616\u2013627. https:\/\/doi.org\/10.1016\/j.jchf.2023.07.014","journal-title":"JACC Heart Fail"},{"issue":"11","key":"10646_CR67","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.jacc.2014.04.008","volume":"64","author":"FM Kusumoto","year":"2014","unstructured":"Kusumoto FM, Calkins H, Boehmer J et al (2014) HRS\/ACC\/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. J Am Coll Cardiol 64(11):1143\u20131177. https:\/\/doi.org\/10.1016\/j.jacc.2014.04.008","journal-title":"J Am Coll Cardiol"},{"key":"10646_CR68","doi-asserted-by":"crossref","unstructured":"Pio SM, Medvedofsky D, Delgado V, COAPT Trial Investigators et al (2024) Left atrial improvement in patients with secondary mitral regurgitation and heart failure: the COAPT trial. JACC Cardiovasc Imaging 17:1015\u201327","DOI":"10.1016\/j.jcmg.2024.03.016"},{"key":"10646_CR69","unstructured":"Writing Committee Members, Lawton JS, Tamis-Holland JE et al 2021 ACC\/AHA\/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines"},{"issue":"1","key":"10646_CR70","doi-asserted-by":"publisher","first-page":"30","DOI":"10.31083\/j.rcm2301030)","volume":"23","author":"X Zhi Shang","year":"2022","unstructured":"Zhi Shang X, Wang W, Gao (2022) Heart failure with mildly reduced ejection fraction: emerging frontiers in clinical characteristics, prognosis, and treatment. Rev Cardiovasc Med 23(1):30. https:\/\/doi.org\/10.31083\/j.rcm2301030)","journal-title":"Rev Cardiovasc Med"},{"issue":"20","key":"10646_CR71","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1093\/eurheartj\/ehy005","volume":"39","author":"CSP Lam","year":"2018","unstructured":"Lam CSP, Gamble GD, Ling LH et al (2018) Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study. Eur Heart J 39(20):1770\u20131780. https:\/\/doi.org\/10.1093\/eurheartj\/ehy005","journal-title":"Eur Heart J"},{"key":"10646_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ahj.2020.07.009","volume":"229","author":"CR Olsen","year":"2020","unstructured":"Olsen CR, Mentz RJ, Anstrom KJ, Page D, Patel PA (2020) Clinical applications of machine learning in the diagnosis, classification, and prediction of heart failure. Am Heart J 229:1\u201317. https:\/\/doi.org\/10.1016\/j.ahj.2020.07.009","journal-title":"Am Heart J"},{"issue":"23","key":"10646_CR73","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1016\/j.jacc.2012.04.064","volume":"60","author":"RT Campbell","year":"2012","unstructured":"Campbell RT, Jhund PS, Castagno D et al (2012) What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-Preserve. J Am Coll Cardiol 60(23):2349\u20132356. https:\/\/doi.org\/10.1016\/j.jacc.2012.04.064","journal-title":"J Am Coll Cardiol"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-026-10646-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-026-10646-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-026-10646-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T19:01:48Z","timestamp":1783710108000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-026-10646-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10646"],"URL":"https:\/\/doi.org\/10.1007\/s10741-026-10646-y","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"9 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}